Katrice Lowe
Primary Care · Tuscaloosa, ALNPI 1811558455
Payments from drug & device makers
Across 16 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$69
- Otsuka America Pharmaceutical, Inc.$54
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$44
- AstraZeneca$36
- Lilly USA, LLC$36
- AbbVie$29
- plus $29 from 2 others
What the payments were for
- Food & beverage$295100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $44 |
| AstraZeneca | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| AbbVie | 1 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
How this compares
$295 in reported general payments places this provider in the 35th percentile of 159 primary care providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate HfaFluticasone Propionate | 11 | $2,450 |
| Memantine Hcl | 27 | $587 |
| Nebivolol Hcl | 11 | $442 |
| Levothyroxine Sodium | 35 | $435 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $408 |
| Midodrine Hcl | 11 | $329 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $314 |
| Duloxetine Hcl | 21 | $267 |
| Mirtazapine | 22 | $240 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 12 | $233 |
| Tamsulosin Hcl | 14 | $227 |
| Baclofen | 18 | $210 |
| Methylprednisolone | 30 | $201 |
| Losartan Potassium | 22 | $201 |
| Levocetirizine Dihydrochloride | 22 | $200 |
Paid to pharmacies, not to this prescriber.
Other primary care in Tuscaloosa
- Laura PowellTuscaloosa$4K
- Brandi TorresTuscaloosa$4K
- Lorraine WatkinsTuscaloosa$2K
- Rachel JollyTuscaloosa$2K
- Keith MatthewsOpelika$20K
- Troy HendersonFultondale$18K
- Samantha WilliamsBirmingham$18K
- April TateDothan$16K
- Brandy McGrawMobile$14K
- Cleo ValdezHuntsville$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.